{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T21:04:31Z","timestamp":1778360671858,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,10]]},"DOI":"10.7759\/cureus.89738","type":"journal-article","created":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T17:24:44Z","timestamp":1754846684000},"source":"Crossref","is-referenced-by-count":1,"title":["A Rare Coexistence of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis and IgG4-Related Disease: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Zainulabdeen S","family":"Al-saedi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Alatta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed A","family":"Miqdad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Hulwi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mourhege","family":"Alsaloum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.103","article-title":"Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease","volume":"10","author":"Jennette JC","year":"2014","unstructured":"Jennette JC, Falk RJ. Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat Rev Rheumatol. 2014, 10:463-73. 10.1038\/nrrheum.2014.103","journal-title":"Nat Rev Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.104","article-title":"Key advances in the clinical approach to ANCA-associated vasculitis","volume":"10","author":"Kallenberg CG","year":"2014","unstructured":"Kallenberg CG. Key advances in the clinical approach to ANCA-associated vasculitis. Nat Rev Rheumatol. 2014, 10:484-93. 10.1038\/nrrheum.2014.104","journal-title":"Nat Rev Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone JH","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R, et al.. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010, 363:221-32. 10.1056\/NEJMoa0909905","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone JH","year":"2012","unstructured":"Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012, 366:539-51. 10.1056\/NEJMra1104650","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0500-7","article-title":"IgG4-related disease: an update on pathophysiology and implications for clinical care","volume":"16","author":"Perugino CA","year":"2020","unstructured":"Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol. 2020, 16:702-14. 10.1038\/s41584-020-0500-7","journal-title":"Nat Rev Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2023.12.001","article-title":"IgG4-related kidney disease: clinicopathologic features, differential diagnosis, and mimics","volume":"41","author":"Gilani SI","year":"2024","unstructured":"Gilani SI, Buglioni A, Cornell LD. IgG4-related kidney disease: clinicopathologic features, differential diagnosis, and mimics. Semin Diagn Pathol. 2024, 41:88-94. 10.1053\/j.semdp.2023.12.001","journal-title":"Semin Diagn Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-023-05419-x","article-title":"Coexistence of IgG4-related disease and ANCA-associated vasculitis: case report and review of the literature","volume":"44","author":"Korkmaz C","year":"2024","unstructured":"Korkmaz C, Y\u0131ld\u0131r\u0131m R, Dinler M, Cansu DU. Coexistence of IgG4-related disease and ANCA-associated vasculitis: case report and review of the literature. Rheumatol Int. 2024, 44:557-72. 10.1007\/s00296-023-05419-x","journal-title":"Rheumatol Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-021-00620-y","article-title":"Tubulointerstitial nephritis in antineutrophil cytoplasmic antibody-associated vasculitis with monoclonal gammopathy","volume":"11","author":"Hishida E","year":"2022","unstructured":"Hishida E, Kobayashi T, Ono Y, et al.. Tubulointerstitial nephritis in antineutrophil cytoplasmic antibody-associated vasculitis with monoclonal gammopathy. CEN Case Rep. 2022, 11:36-42. 10.1007\/s13730-021-00620-y","journal-title":"CEN Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-012513-104708","article-title":"IgG4-related disease","volume":"9","author":"Mahajan VS","year":"2014","unstructured":"Mahajan VS, Mattoo H, Deshpande V, Pillai SS, Stone JH. IgG4-related disease. Annu Rev Pathol. 2014, 9:315-47. 10.1146\/annurev-pathol-012513-104708","journal-title":"Annu Rev Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/art.39132","article-title":"International consensus guidance statement on the management and treatment of IgG4-related disease","volume":"67","author":"Khosroshahi A","year":"2015","unstructured":"Khosroshahi A, Wallace ZS, Crowe JL, et al.. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015, 67:1688-99. 10.1002\/art.39132","journal-title":"Arthritis Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.31662\/jmaj.2024-0096","article-title":"Recent evidence of the role of CD4(+) T cell subsets in IgG4-related disease","volume":"8","author":"Kamekura R","year":"2025","unstructured":"Kamekura R, Sakamoto H, Yajima R, et al.. Recent evidence of the role of CD4(+) T cell subsets in IgG4-related disease. JMA J. 2025, 8:40-7. 10.31662\/jmaj.2024-0096","journal-title":"JMA J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2017.1354698","article-title":"Diagnostic and treatment workup for IgG4-related disease","volume":"13","author":"Abraham M","year":"2017","unstructured":"Abraham M, Khosroshahi A. Diagnostic and treatment workup for IgG4-related disease. Expert Rev Clin Immunol. 2017, 13:867-75. 10.1080\/1744666X.2017.1354698","journal-title":"Expert Rev Clin Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.787422","article-title":"The role of IgG4 in autoimmunity and rheumatic diseases","volume":"12","author":"Maslinska M","year":"2021","unstructured":"Maslinska M, Dmowska-Chalaba J, Jakubaszek M. The role of IgG4 in autoimmunity and rheumatic diseases. Front Immunol. 2021, 12:787422. 10.3389\/fimmu.2021.787422","journal-title":"Front Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.40","article-title":"Elevated serum IgG4 levels in diagnosis, treatment response, organ involvement, and relapse in a prospective IgG4-related disease UK cohort","volume":"111","author":"Culver EL","year":"2016","unstructured":"Culver EL, Sadler R, Simpson D, et al.. Elevated serum IgG4 levels in diagnosis, treatment response, organ involvement, and relapse in a prospective IgG4-related disease UK cohort. Am J Gastroenterol. 2016, 111:733-43. 10.1038\/ajg.2016.40","journal-title":"Am J Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/232960","article-title":"Spectrum of disorders associated with elevated serum IgG4 levels encountered in clinical practice","volume":"2012","author":"Ryu JH","year":"2012","unstructured":"Ryu JH, Horie R, Sekiguchi H, Peikert T, Yi ES. Spectrum of disorders associated with elevated serum IgG4 levels encountered in clinical practice. Int J Rheumatol. 2012, 2012:232960. 10.1155\/2012\/232960","journal-title":"Int J Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2019.06.018","article-title":"Biomarkers in IgG4-related disease: a systematic review","volume":"50","author":"Tang J","year":"2020","unstructured":"Tang J, Cai S, Ye C, Dong L. Biomarkers in IgG4-related disease: a systematic review. Semin Arthritis Rheum. 2020, 50:354-9. 10.1016\/j.semarthrit.2019.06.018","journal-title":"Semin Arthritis Rheum"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2013.05.023","article-title":"IgG4-positive plasma cells in granulomatosis with polyangiitis (Wegener's): a clinicopathologic and immunohistochemical study on 43 granulomatosis with polyangiitis and 20 control cases","volume":"44","author":"Chang SY","year":"2013","unstructured":"Chang SY, Keogh KA, Lewis JE, Ryu JH, Cornell LD, Garrity JA, Yi ES. IgG4-positive plasma cells in granulomatosis with polyangiitis (Wegener's): a clinicopathologic and immunohistochemical study on 43 granulomatosis with polyangiitis and 20 control cases. Hum Pathol. 2013, 44:2432-7. 10.1016\/j.humpath.2013.05.023","journal-title":"Hum Pathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13693","article-title":"Do ANCA-associated vasculitides and IgG4-related disease really overlap or not?","volume":"22","author":"Erden A","year":"2019","unstructured":"Erden A, Bolek EC, Yardimci KG, Kilic L, Bilgen SA, Karadag O. Do ANCA-associated vasculitides and IgG4-related disease really overlap or not?. Int J Rheum Dis. 2019, 22:1926-32. 10.1111\/1756-185X.13693","journal-title":"Int J Rheum Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cdtm.2017.05.003","article-title":"Immunoglobulin G4-related kidney disease: Pathogenesis, diagnosis, and treatment","volume":"3","author":"Zheng K","year":"2017","unstructured":"Zheng K, Teng F, Li XM. Immunoglobulin G4-related kidney disease: Pathogenesis, diagnosis, and treatment. Chronic Dis Transl Med. 2017, 3:138-47. 10.1016\/j.cdtm.2017.05.003","journal-title":"Chronic Dis Transl Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.05.009","article-title":"Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention","volume":"62","author":"Kallenberg CG","year":"2013","unstructured":"Kallenberg CG, Stegeman CA, Abdulahad WH, Heeringa P. Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention. Am J Kidney Dis. 2013, 62:1176-87. 10.1053\/j.ajkd.2013.05.009","journal-title":"Am J Kidney Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003082","article-title":"Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): part 1-treatment of granulomatosis with polyangiitis and microscopic polyangiitis","volume":"9","author":"Schirmer JH","year":"2023","unstructured":"Schirmer JH, Sanchez-Alamo B, Hellmich B, Jayne D, Monti S, Luqmani RA, Tomasson G. Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): part 1-treatment of granulomatosis with polyangiitis and microscopic polyangiitis. RMD Open. 2023, 9:e003082. 10.1136\/rmdopen-2023-003082","journal-title":"RMD Open"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.08.007","article-title":"Treatment of ANCA-associated vasculitides (AAV)","volume":"12","author":"Holle JU","year":"2013","unstructured":"Holle JU, Gross WL. Treatment of ANCA-associated vasculitides (AAV). Autoimmun Rev. 2013, 12:483-6. 10.1016\/j.autrev.2012.08.007","journal-title":"Autoimmun Rev"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3182431ef6","article-title":"Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients","volume":"91","author":"Khosroshahi A","year":"2012","unstructured":"Khosroshahi A, Carruthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore). 2012, 91:57-66. 10.1097\/MD.0b013e3182431ef6","journal-title":"Medicine (Baltimore)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac623","article-title":"Diagnosing and treating ANCA-associated vasculitis: an updated review for clinical practice","volume":"62","author":"Chevet B","year":"2023","unstructured":"Chevet B, Cornec D, Casal Moura M, et al.. Diagnosing and treating ANCA-associated vasculitis: an updated review for clinical practice. Rheumatology (Oxford). 2023, 62:1787-803. 10.1093\/rheumatology\/keac623","journal-title":"Rheumatology (Oxford)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/396236-a-rare-coexistence-of-antineutrophil-cytoplasmic-antibody-anca-associated-vasculitis-and-igg4-related-disease-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T17:24:44Z","timestamp":1754846684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/396236-a-rare-coexistence-of-antineutrophil-cytoplasmic-antibody-anca-associated-vasculitis-and-igg4-related-disease-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,10]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.89738","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,10]]}}}